Carbidopa Impurities and its Related Products



Displaying 17 results of Carbidopa Impurities

Carbidopa is a medication used in the treatment of Parkinson's disease. During the manufacturing process of Carbidopa, impurities may be formed as a result of chemical reactions or contamination. These impurities can affect the quality and purity of the drug, potentially leading to adverse effects in patients. Therefore, it is important to monitor and control the levels of impurities in Carbidopa to ensure its safety and efficacy.
COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
(S)-Carbidopa Methyl Ester N-Cyclohexylidene Impurities CS-T-71470 934371-48-9 Enquire
2-Bromo (S)-Carbidopa Impurities CS-T-67232 43197-33-7 Enquire
3,4-O,O-Dimethyl Carbidopa Impurities CS-O-59819 937203-35-5 Enquire
3-O-Methyl Carbidopa Impurities CS-T-58059 85933-19-3 Enquire
Carbidopa EP Impurity B Impurities CS-EO-00019 18181-08-3 Enquire
Carbidopa EP Impurity C Impurities CS-O-33871 84488-77-7 Enquire
Carbidopa EP Impurity E Impurities CS-T-50258 52514-63-3 In Stock
Carbidopa EP Impurity F Impurities CS-O-12052 1458640-32-8 Discontinued
Carbidopa EP Impurity I (Racemic) Impurities CS-T-49530 1246819-09-9 Enquire
Carbidopa EP Impurity J Impurities CS-T-49529 1246817-47-9 Enquire
Carbidopa Ethyl Ester Hydrochloride Impurities CS-P-07470 96115-88-7 Enquire
Carbidopa monohydrate Impurities CS-M-34857 38821-49-7 Enquire
DL-Carbidopa Impurities CS-T-50252 302-53-4 In Stock
Methyl 3-(3,4-dihydroxyphenyl)-2-methyl propanoate Impurities CS-O-53173 2104012-68-0 Enquire
Rac-Carbidopa EP Impurity H Impurities CS-O-38880 2470439-16-6 Enquire
rac-Carbidopa Methyl Ester Impurities CS-T-71242 91431-01-5 Enquire
rac-Carbidopa Methyl Ester methyl sulphonate salt Impurities CS-O-57702 91431-01-5 (freebase) Enquire